558 related articles for article (PubMed ID: 8445832)
1. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
Korbet SM
Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832
[No Abstract] [Full Text] [Related]
2. The adverse effects of recombinant human erythropoietin therapy.
Wong KC; Li PK; Lui SF; Nicholls MG; Lai KN
Adverse Drug React Acute Poisoning Rev; 1990; 9(4):183-206. PubMed ID: 2088088
[No Abstract] [Full Text] [Related]
3. Indications and contraindications for recombinant human erythropoietin treatment. Results in hemodialysis patients.
Samtleben W; Baldamus CA; Bommer J; Grützmacher P; Nonnast-Daniel B; Scigalla P; Gurland HJ
Contrib Nephrol; 1989; 76():193-200; discussion 212-8. PubMed ID: 2684521
[No Abstract] [Full Text] [Related]
4. Seizures in dialysis patients treated with recombinant erythropoietin.
Beccari M; Romagnoni M; Sorgato G
Nephrol Dial Transplant; 1995; 10(3):423-4. PubMed ID: 7792048
[No Abstract] [Full Text] [Related]
5. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N
Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072
[TBL] [Abstract][Full Text] [Related]
6. [Erythropoietin treatment in children with chronic renal failure].
Ito K; Hattori M
Nihon Rinsho; 1991 Dec; 49 Suppl():688-94. PubMed ID: 1808336
[No Abstract] [Full Text] [Related]
7. Comparison of hemodialysis and peritoneal dialysis in the management of anemia related to chronic renal disease.
Korbet SM
Semin Nephrol; 1989 Mar; 9(1 Suppl 1):9-15. PubMed ID: 2648520
[TBL] [Abstract][Full Text] [Related]
8. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
Stojimirović B; Grujić-Adanja G
Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
[TBL] [Abstract][Full Text] [Related]
9. Blood rheology in hemodialysis patients treated with recombinant human erythropoietin.
Brunner R; Pollok M; Heidel M; Müller R; Degenhardt S; Baldamus CA
Contrib Nephrol; 1989; 76():306-12; discussion 312-4. PubMed ID: 2582784
[No Abstract] [Full Text] [Related]
10. Erythropoietin use in peritoneal dialysis patients.
Zimmerman SW; Johnson CA
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):38-41. PubMed ID: 1928078
[TBL] [Abstract][Full Text] [Related]
11. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis].
Litwin M; Boguszewska-Baczkowska A; Jelonek A
Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):135-6. PubMed ID: 8090665
[TBL] [Abstract][Full Text] [Related]
12. The long-term effects of recombinant human erythropoietin on the cardiovascular system.
Eschbach JW; Aquiling T; Haley NR; Fan MH; Blagg CR
Clin Nephrol; 1992; 38 Suppl 1():S98-103. PubMed ID: 1295715
[TBL] [Abstract][Full Text] [Related]
13. Treatment of anaemia in CAPD patients with recombinant human erythropoietin.
Ramello A; Malcangi U; Bruno M; Perosa P; Reina E; Rizzuto A; Nasini MG; Carozzi S
Adv Perit Dial; 1990; 6():308-11. PubMed ID: 1982834
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin treatment improves quality of life in hemodialysis patients.
Bárány P; Pettersson E; Bergström J
Scand J Urol Nephrol Suppl; 1990; 131():55-60. PubMed ID: 2075471
[TBL] [Abstract][Full Text] [Related]
15. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
Eschbach JW; Haley NR; Adamson JW
Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
[No Abstract] [Full Text] [Related]
16. Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.
Binkley LS
Transplant Proc; 1991 Apr; 23(2):1831-2. PubMed ID: 2053169
[No Abstract] [Full Text] [Related]
17. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
von Appen K; Klinkmann H
Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
[No Abstract] [Full Text] [Related]
18. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
[TBL] [Abstract][Full Text] [Related]
19. Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA).
Krapf R; Hulter HN
Clin J Am Soc Nephrol; 2009 Feb; 4(2):470-80. PubMed ID: 19218474
[TBL] [Abstract][Full Text] [Related]
20. Effect of recombinant human erythropoietin treatment on hemodynamic parameters in continuous ambulatory peritoneal dialysis and hemodialysis patients.
Fernández A; Vega N; Jiménez F; Macía M; Laraudiogoitía E; Hortal L; Perdomo M; Plaza C; Rodríguez JC; Palop L
Am J Nephrol; 1992; 12(4):207-11. PubMed ID: 1481867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
